Summary
The low interference with growth expected in child for a cortisol analogue, deflazacort (DFZ), prompted us to verify if DFZ could affect growth less than prednisone (PDN). An interim analysis relative to 27 girls and 38 boys (out of 100 expected) age 3–12 yrs, after a median period of 14 mo.s is reported. Children with connective tissues (CTD) and glomerular disorders (KD) were randomly allocated to DFZ or PDN. Anthropometric measurements and maturity ratings were performed. Mean daily doses of PDN (or DFZ equivalent), from 0.57 to 0.64 mg/kg (DFZ 0.92 to 0.94 mg/kg) to induce control and from 0.19 to 0.93 mg/kg (DFZ 0.34 to 0.36 mg/kg) to maintain disease under control were given in CTD and KD, respectively. The increase in bone age delay over time was significantly>for PDN(-4.0 mo/yr) than DFZ (-1.8 mo/yr) in the overall group. The increases in statural age delay and loss over time were significantly> for PDN (-5.9 and-5.9 mo/yr) than DFZ (-2.4 and-2.4 mo/yr), only in children with “taller” midparents. Although doses of DFZ 1.1–1.8 times those of PDN were given, growth retardation in PDN-treated children was nevertheless 2.3–2.5 times that in DFZ-ones.
References
Loeb JN (1976). Corticosteroids and growth. New Engl J Med: 295, 547–552
Henderson IC, Loeb JN (1974). Hormone-induced changes in liver DNA synthesis: effects of glucocorticoids and growth hormone on liver growth and DNA polymerase activity. Endocrinology: 94, 1637–1643
Morris HG, Jorgensen JR, Elrich H, Goldsmith RE (1968). Metabolic effects of human growth hormone in corticosteroid-treated children., J Clin Invest: 47, 436–451
Daughaday WH, Herington AC, Phillips LS (1975). The regulation of growth by endocrines. Annu Rev Physiol: 37, 211–244
Nathanshon G, Pasqualucci GR, Radaelli P, Schiatti P, Selva D, Winters G (1969). Steroids possessing nitrogen atoms. V(1) Some pharmacological and chemicophysical aspects of a new class of active corticoids: (17 alfa, 16 alfa-D)-oxazolino-steroids. Steroids: 13, 365–381
Hahn TJ Halstead LR, Strates B, Imbimbo B, Baran DT (1980). Comparison of subacute effects of oxazacort and prednisone on mineral metabolism in man. Calcif Tissue Int: 31, 109–115
Gennari C, Imbimbo B, Montagnani M, Bernini M, Nardi P, Avioli LV (1984). Effects of prednisone and deflazacort on mineral metabolism and parathyroid hormone activity in humans Calcif Tissue Int: 36, 245–252
Gennari C, Bernini M, Nardi P, Fusi L, Francini G, Nami R, Montagnani M, Imbimbo B, Avioli LV (1983). Glucocorticoids: radiocalcium and radiophosphate absorption in man. In: Dixon ASJ, Russell RGG, Stamp TCB eds. Osteoporosis, a multidisciplinary problem. Royal Society of Medicine. Int congress and symposium series, No 55. Academic Press, London, p. 75–80.
Imbimbo B, Tuzi T, Porzio F, Schiavetti L (1984). Clinical equivalence of a new glucocorticoid, deflazacort and prednisone in rheumatoid arthritis and S.L.E. patients. Adv Exp Med Biol: 171, 241–256
Imbimbo B, Milani S (1986). Equivalenza clinica e tollerabilità relativa dei glucocorticoidi: stima dei rapporti di potenza e di danno. In: Avioli LV, Gennari G, Imbimbo B eds. Glucocorticoid effects and their biological consequences: advances in glucocorticoid therapy. Excerpta Medica, Amsteram, p. 13–22
Lo Cascio V, Bonucci E, Imbimbo B, Ballanti P, Tartarotti D, Galvanin, G, Fuccella L and Adami S (1984). Bone loss after glucocorticoids therapy. Calcif Tissue Int: 36, 435–438
Gennari C, Imbimbo B (1985). Effects of prednisone and deflazacort on vertebral bone mass. Calcif Tissue Int: 37, 592–593
Nagant de Deuxchaisnes C, Devogelaer JP, Huaux JP, Dufour JP, Esselinckx W, Stasse P (1986). The effect of small equivalent doses of deflazacort and prednisone on the bone mineral content in male patients with rheumatoid arthritis. J Bone Mineral Res, suppl 1: abstract No. 172
Balsan S, Steru D, Bourdeau A, Grimberg R, Lenoir C (1987). Effects of long-term maintenance therapy with a new glucocorticoid, deflazacort, on mineral metabolism and statural growth. Calcif Tissue Int: 40, 303–309
Cameron N (1984). The measurement of human growth. Croom-Helm, London
Tanner JM, Whitehouse RH (1976). Clinical longitudinal standards for height, weight, height velocity and weight velocity and the stages of puberty. Arch Dis Child: 51, 170–179
Tanner JM, Whitehouse RH (1975). Revised standards for triceps and subscapular skinfolds in British children. Arch Dis Child: 50, 142-?
Aicardi C, Di Battista E, Naselli A, Vignolo M, De Scrilli A (1986). Affidabilità dei più comuni metodi di previsione della statura adulta su un campione di adolescenti Italiani. Acta Med Auxol: 18, 55–65
Tanner JM, Whitehouse RH, Cameron N, Marshall WA, Healy MJR, Goldstein H (1983). Assessment of skeletal maturity and prediction of adult height (TW2 method), 2nd ed. Academic Press, London
Roche AF, Wainer H, Thissen D (1975). Predicting adult stature for individuals. Monogr Pediatr: 3, 1–114
Vignolo M, Milani S, Di Battista E, Naselli A, Mostert M, Aicardi G (1990). Modified Greulich-Pyle, Tanner-Whitehouse and Roche-Wainer-Thissen (Knee) methods for skeletal age assessment in a group of Italian children and adolescents. Eur J Pediatr: 149, 314
Tanner JM (1986). Use and abuse of growth standards. In: F. Falkner and JM Tanner eds, vol 3. Plenum Press, New York, p. 104
Searle SR (1971). Linear models. Wiley, London
SAS Institute Inc (1985). SAS introductory guide for personal computers. 6th ed. Cary
Loftus JK, Allen R, Hesp R, Green JR, Reeve J, Ansell BM, Woo P (1989). A comparative trial of deflazacort and prednisone in Juvenile Chronic Arthritis. Am Soc Bone Mineral Res, Int Conference on Calcium and Related Hormones. Montreal, 14 Sept
Loftus JK, Allen R, Hesp R, Green JR, Reeve J, Ansell BM, Woo P (1990). Treatment of Juvenile Chronic Arthritis (JCA): Deflazacort permits proportionate growth in lumbar spine bone mineral content in a randomized trial with prednisone. Clin Sci, Suppl 22: 4, 13
Blodgett FM, Burgin L, Lezzoni D, Gribetz D, Talbot NB (1956). Effect of prolonged cortisone treatment on the statural growth, skeletal maturation and metabolic status of children. New Engl J Med: 254, 636–641
Kerrebijn KF, Kroon JPM (1968). Effect on height of corticosteroid therapy in asthmatic children. Arch Dis Child: 43, 556
Mosier HD Jr, Jansons RA, Hill RR (1976). Cartilage sulfation cortisone-induced growth arrest. Endocrinology: 99, 580
Gutman AB, Yu TF (1950). A concept of the role of enzymes in endochondral calcification In: Metabolic interrelations. Transactions second conference Josiah Macy Foundation, New York, p. 167
Meyer WL, Kunin AS (1969). Decreased glycolytic enzyme activity in epyphyseal cartilage of cortisome-treated rats. Arch Biochem Biophys: 129, 431–437
Russell JE, Gennari C, Imbimbo B, Avioli LV (1985). Effects of deflazacort and L-6485 metabolite on epyphyseal cartilage carbohydrate metabolism: comparison with prednisone. Horm Metabol Res: 17, 402–405
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Aicardi, G., Milani, S., Imbimbo, B. et al. Comparison of growth retarding effects induced by two different glucocorticoids in prepubertal sick children: An interim long-term analysis. Calcif Tissue Int 48, 283–287 (1991). https://doi.org/10.1007/BF02556381
Issue Date:
DOI: https://doi.org/10.1007/BF02556381